Business Description
Pharmadrug Inc
NAICS : 325411
SIC : 3741
ISIN : CA5134413031
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.11 | |||||
Equity-to-Asset | -1.61 | |||||
Debt-to-Equity | -0.99 | |||||
Debt-to-EBITDA | -0.1 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -5.6 | |||||
3-Year EPS without NRI Growth Rate | 48.3 | |||||
3-Year FCF Growth Rate | 48.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 66.46 | |||||
9-Day RSI | 54.54 | |||||
14-Day RSI | 51.61 | |||||
6-1 Month Momentum % | -28.57 | |||||
12-1 Month Momentum % | -28.57 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.13 | |||||
Quick Ratio | 0.13 | |||||
Cash Ratio | 0.07 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -36.7 | |||||
Shareholder Yield % | -18.5 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -565.88 | |||||
ROA % | -247.18 | |||||
ROIC % | -21.48 | |||||
ROCE % | -472.3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.24 | |||||
EV-to-EBITDA | -0.24 | |||||
EV-to-FCF | -3.44 | |||||
Earnings Yield (Greenblatt) % | -416.67 | |||||
FCF Yield % | -45.25 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Pharmadrug Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | |||
EPS (TTM) (C$) | -0.229 | ||
Beta | 0.49 | ||
Volatility % | 153.16 | ||
14-Day RSI | 51.61 | ||
14-Day ATR (C$) | 0.002641 | ||
20-Day SMA (C$) | 0.01925 | ||
12-1 Month Momentum % | -28.57 | ||
52-Week Range (C$) | 0.005 - 0.075 | ||
Shares Outstanding (Mil) | 106.73 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Pharmadrug Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Pharmadrug Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Pharmadrug Inc Frequently Asked Questions
What is Pharmadrug Inc(XCNQ:PHRX)'s stock price today?
When is next earnings date of Pharmadrug Inc(XCNQ:PHRX)?
Does Pharmadrug Inc(XCNQ:PHRX) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |